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Abstract
This thesis introduces statistical analysis methods for two types of bacterial
data: metabolic data produced by phenotype microarray technology, and
genomic data produced by sequencing technologies. As both technologies
produce vast amounts of data, as well as have special features, there is a
need for bioinformatics tools that adequately process and analyze the infor-
mation produced. Similar to all biomolecular data analyses, the interplay
between biological components poses an additional challenge to the method
development. A speciﬁc complication, regarding the metabolic data, is the
lack of larger quantities of replicates due to the high expenses of perform-
ing the experiments. In terms of the sequence data, genome-wide analysis
tools are desired, since such methods have not yet been widely developed for
bacteria, even though they exist for eukaryotic genetics. The thesis brieﬂy
reviews the current methods, and introduces new approaches tackling the
above mentioned problems.
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Chapter 1
Introduction
The revolution of measurement technology has also revolutionized the study
of cells on molecular level within the past decades, for example, the human
genome was ﬁrst sequenced in 2001 [1,2]. Back then it required 13 years to
complete the work. After that basal work the developments to the sequenc-
ing machines have been enormous, reducing the time spent to sequence a
human genome ﬁrst to days, and recently to hours. The advances in the
sequencing technology have led to substantial reductions in the costs as
well, allowing sequencing to become a standard procedure in health care
used for clinical diagnostic testing [3,4]. Sequencing techniques are not the
only measurement techniques improved, other examples include DNA mi-
croarrays, mass spectrometry, and cellular imaging by microscopy [5]. One
such measurement technique is Biolog phenotype microarray technology
elaborated in this thesis [6].
The biomolecular measurement techniques of this era produce vast
amounts of digital data, creating the need for computational tools to eﬀec-
tively process the data and to handle both biological and technical noise
embedded in the observations. In this thesis, we focus on developing such
analysis tools for Biolog phenotype microarray data as well as for DNA se-
quence data. Especially, we concentrate on detecting similarities or diﬀer-
ences in either the metabolic or genomic composition of bacterial samples.
The statistical R programming environment is mainly utilized to accom-
plish the tasks.
Biolog phenotype microarrays measure the metabolic activity of cells
in thousands of predetermined conditions, and are mainly applied to bac-
teria [7–9], even though the metabolic activity of fungi [10], yeast [11],
human [12] or virus infected cells [13] can be studied as well. Not many
publicly available tools exist for processing, exploring and analyzing the
data which by nature are multidimensional, as thousands of phenotypes
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can be monitored at once, and followed over a period of time. Thus, we
developed a pipeline from preprocessing to the detection of diﬀerentially
metabolized samples. The former includes steps such as background cor-
rection and normalization, and the latter can be achieved, for example,
by variance or factor analysis. The approaches we have developed are de-
scribed in articles I and II.
The DNA sequence data addressed in this thesis are bacterial as well,
and the aim is to track genetic variants associated with a phenotype of
interest, such as antibiotic, or multi-drug resistance, host, and geograph-
ical location. Such associations between the genetic composition and an
outcome variable are traditionally studied by linkage or genome-wide as-
sociation analyses (GWAS) [14, 15], originally developed to study human
genomes [16,17], but recently also applied to bacteria [18–20]. However, as
human and bacterial cells diﬀer from each other, e.g., in terms of gene con-
tent, recombination rate and clonality, the methods developed for human
lack power to detect associations in bacteria. Our method, called sequence
element enrichment analysis (SEER), tackles the problems of variable gene
content and clonality by using sequence elements, i.e. DNA words of length
k, hence spanning the search of genetic variants to cover the whole genome,
instead of only focusing on the core genome parts, which is done in the
traditional approaches utilizing SNPs (single nucleotide polymorphism).
The non-core genes do often contribute substantially to several phenotypes
of interest, such as antibiotic resistance, and consequently SNPs in core
genes are not necessarily able to discriminate between diﬀerent phenotype
values [21]. So far, SEER has been applied to tens of studies, providing
numerous new insights into the relationships between genotypes and phe-
notypes [21–23]. Article III represents the SEER method, while article IV
introduces an early version of SEER and includes the ﬁrst ever application
of the SEER approach.
This thesis in divided into two parts: Chapter 2 introduces the Biolog
phenotype microarray technology with existing analysis methods as well as
the tools developed here, whereas Chapter 3 focuses on the genome-wide
association analysis of DNA sequence data. Finally, Chapter 4 concludes
the thesis with a discussion. Throughout the thesis, some technical concepts
are highlighted by blue colour, and brieﬂy explained after each section.
3Molecular biology = a science that studies the composition, structure and interactions of cellular
molecules, such as DNA, RNA, and proteins, to understand the complex biological processes
vital to cell maintenance
Bioinformatics = Molecular biology + Statistics + Computer science
Metabolic activity = degree of activity of the process called metabolism through which a cell
gets energy from nutrients to synthesize new proteins, nucleic acids (DNA, RNA), etc.
DNA sequence = a string of nucleotides constructing the genetic material of each living cell
Genetic variant = a section of DNA sequence that diﬀers within or between populations
Recombination = exchange of genetic material between chromosomes (eukaryotes) or cells
(prokaryotes)
Clonality = an oﬀspring inherits the genes of its parent, resulting in an oﬀspring identical, or
nearly so, to its parents
SNP = a single nucleotide diﬀerence at a certain position of the DNA sequence
Whole genome = all the genetic material of an organism
Core genome = genetic material present in all the genomes compared
Non-core gene = a gene not present in all the genomes compared
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Chapter 2
Biolog Phenotype Microarray
(PM) technology
Biolog phenotype microarray (PM) technology is a high-throughput tech-
nique developed at the beginning of the 21st century allowing simultaneous
testing of thousands of phenotypes that represent a signiﬁcant fraction of
the functions cells can perform [6,24,25]. Similar to more common microar-
ray platforms, such as Aﬀymetrix or Illumina, PMs are colorimetric assays,
but instead of gene expression, PMs measure the ability of a cell line to me-
tabolize a biochemical substrate, and hence to produce energy. If energy is
produced, i.e. cell respiration occurs, it is detected as an irreversible colour
change of a redox dye.
Unlike gene expression microarrays that use RNA as an input, PMs
monitor substrate metabolism of living cells. Also, instead of making a
single measurement at a preﬁxed time point, the PM experiment is kinetic,
run over a period of time, usually for 24 or 48 hours, allowing real time
monitoring of the ﬂow of energy production and cell respiration.
As shown in Figure 2.1, when performing a PM experiment, cells are
directly pipetted into 96-well plastic microplates, making a PM experiment
more straightforward to perform than a gene expression study that requires
extraction and reverse transcription of RNA. On the microplates, the 96
wells introduce 96 diﬀerent preconﬁgured tests. In both methods electronic
scanners are used for detecting colour changes. In contrast to RNA mi-
croarrays for which visual inspection is not possible, the results of the PM
approach can be also visually veriﬁed as colouring is detectable by eye as
demonstrated in Figure 2.1
Each well on a PM plate contains a diﬀerent substrate, such as carbon,
nitrogen, phosphorus or sulphur source, hormone, anti-cancer agent or an-
tibiotic, some at varying concentrations. These metabolic substrates on
5
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Figure 2.1: Performing a Biolog phenotype microarray experiment. Left: cells
are pipetted into a 96-well plastic plate containing substrates [www.biolog.com]. Middle: cells
activated by the substrates develop purple colour [www.swanenviron.com/blogDesc.php?id=40].
Right: scanning of the intensity of the colour development can be automated by the OmnilogTM
incubator-reader [biosciences.exeter.ac.uk/facilities/biolog/biologplates].
PM panels can be linked to cellular pathways using public databases such
as KEGG [26].
In some wells, the cells are activated by the given substrate, simultane-
ously reducing the redox dye and forming purple colour, whereas in some
wells the cells are inhibited with little or no colour formed. The inten-
sity of the purple colour is measured and recorded by the accompanied
OmniLogTM incubator-reader, usually every 15 minutes. In each well, the
amount of purple colour reﬂects the amount of cell respiration. As cell
respiration can occur independent of cell growth, PM technology allows
measuring phenotypes that do not necessarily lead to growth. To iden-
tify diﬀerences in substrate metabolism, 20 preconﬁgured PM panels are
available for microbial and 14 for mammalian cells, yielding the capacity of
testing nearly 2,000 and 1,400 diﬀerent response phenotypes in each cate-
gory, respectively. Since the OmnilogTM incubator-reader contains 50 plate
holders, as illustrated in Figure 2.1, almost 5,000 wells can be simultane-
ously monitored.
PMs were originally developed for microbial cells (bacteria, yeast and
fungi) to analyze the eﬀects of loss of gene function [6], but have later
been established also for human cells as understanding changes in sub-
strate metabolism is important in diseases, such as diabetes, obesity, and
cancer [27]. PM panels for human provide carbon and nitrogen substrates
as well as sensitivity tests against ions, hormones, cytokines and well-
established anti-cancer chemical agents. The metabolic proﬁles of diseased
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and healthy cells can be compared against each other to study the metabolic
changes a certain disease state provokes [12, 28]. Other examples of uti-
lizing PM assays are identifying species [29, 30], deﬁning optimal culture
conditions [33], determining gene function [31, 32], or detecting eﬀects of
genetic alterations [12]. These types of research problems are usually stud-
ied by comparing the metabolic proﬁles of diﬀerent cell lines, e.g., normal
versus knock-out, normal versus abnormal or diseased, cancerous versus
non-cancerous, or virus infected versus virus-free. Cells in diﬀerent states
or stages of development or from various tissues can be compared against
each other as well.
High-throughput technique = an advanced experimental tool enabling rapid, eﬀective and
parallel processing of massive amounts of data at once
RNA = a copied segment of DNA which serves as a template for protein synthesis
Kinetic = a process developing over time. In kinetic data, the speed of a chemical reaction is
often of interest.
Reverse transcription of RNA = a process of generating complementary DNA (cDNA) from an
RNA template. In comparison to RNA, cDNA is more stable, and thus preferred in measuring
RNA/gene expression.
Knock-out (gene) = a gene artiﬁcially inactivated
2.1 Analysis methods for PMs
Even though the PM technology has been available for almost two decades,
the concept is not as widely exploited as many other high-throughput meth-
ods, such as gene expression microarrays. The low utilization rate is partly
due to the high costs of setting up a Biolog testing environment as the
OmniLogTM incubator-reader is an expensive investment not all laborato-
ries can aﬀord to, and partly due to the lack of knowledge in analysing the
data. As few scientists are running Biolog experiments the development of
analysis methods has not been especially intensive either, and the majority
of the Biolog data analyses are performed by plotting two metabolic pro-
ﬁles on the top of each other after which diﬀerential metabolism is detected
either by visual inspection or based on arbitrary cut-oﬀ values [6, 24, 25].
Additionally, the experiments are often performed on a limited number of
samples and replicates, thus hindering a proper analysis of the resulting
data and complicating the interpretation of the results.
As demonstrated in Figure 2.2, the software included in the OmniLogTM
system allows the comparison of two strains based on a 96-panel chart with
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graphically overlaid metabolic proﬁles. The amount of purple colour formed
in each of the 96 wells throughout the time course of an experiment is repre-
sented as curves in the 96 panels. When comparing two metabolic proﬁles,
one proﬁle is shown by green, the other by red, and the overlapping area
by yellow colour. Additionally, the software calculates parameters from the
kinetic data, such as the minimum, maximum and average response, area
under the curve (AUC), the length of the lag phase and slope. Any of the
above-mentioned kinetic parameters can be utilized to highlight the wells
in which the metabolic activity between the two proﬁles diﬀers more than
a given threshold. Clearly, no statistically sound inference is made when
comparing two curves without replicates, and using an arbitrary thresh-
old. Another disadvantage, related to using a single summary statistic
to describe a curve which originally comprises hundreds of data points, is
loss of information concerning the shape of the underlying curve. For in-
stance, two curves may have very similar average response and AUC, but
yet clearly diﬀer in their shapes, for example, in terms of the length of lag
phase, maximal growth rate and maximum response [34].
In a Biolog experiment, the colour accumulates irreversibly, thus the
recorded metabolic proﬁles are increasing curves, enabling the use of growth
models in the analysis of PM data. Several models have been suggested to
ﬁt the Biolog metabolic growth curves, such as logistic, Gompertz, Lind-
strom, Richard, Baranyi, and Diauxic [11,34–37]. After ﬁtting a model, the
curves are compared in a similar fashion as above, but using the model-
based parameters instead of the non-model-based summaries, the beneﬁt
being that the standard errors of the estimated parameters can be utilized
in assessing statistically signiﬁcant diﬀerences. The disadvantage of the
model-based approach is that there exists no single model that could de-
pict the variety of curve shapes introduced by Biolog experiments [34, 37].
Ideally, the same model should be ﬁtted to all metabolic curves to be reli-
ably able to compare the resulting parameter estimates, since the parame-
ters of diﬀerent models might not be comparable. Gerstgrasser et al. [34]
solves this problem by ﬁtting several models, and using summary statistics
calculated on the basis of the ﬁtted curves instead of the model parameters.
Probably the most widely used and comprehensive package for reading
in, processing, and visualizing PM data was introduced by Vaas et al. [37].
The R package is called opm, and it ﬁts Gompertz’s and Richard’s models to
the Biolog metabolic activity proﬁles, and also provides a model-free spline
ﬁt. Diﬀerences between the parameters of diﬀerent curves can be evaluated
based on the 95 % conﬁdence intervals of the estimated parameters.
As stated above, Biolog experiments are often performed with no or few
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Figure 2.2: Comparison of two samples. A Biolog phenotype microarray experiment is
performed to compare the metabolic activity of samples A and B. Left: Two 96-well PM plates are
loaded with cells from two diﬀerent cell lines. Purple colour starts to develop if the substrate in
a well triggers metabolism. The darker the colour is, the more metabolically active the cells are.
Middle: The plates are placed in the OmniLogTM incubator-reader which tracks the amount
of purple colour produced in the wells for a period of time. Top right: The output from the
scanner is time-series data indicative of the metabolic activity of the cells under the conditions
provided in each well. The metabolic activities of the samples A and B are represented by red
and green colours, respectively. The overlapping section is coloured by yellow. Bottom right:
Several summary statistics can be extracted from the metabolic activity curves, such as length
of lag phase, maximum growth rate, area under the curve (AUC), or minimum and maximum
signal.
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replicates complicating the statistical analyses. However, if an experiment
is repeated several times, statistical tests, e.g. t-test (for two groups) or
ANOVA (for several groups) can be applied to the parameters summariz-
ing the proﬁles [38]. If several samples are available, the parameter vectors
can be collected into a matrix as illustrated in Figure 2.3, a covariance or
distance matrix computed, and used as an input, for instance, for factor
analysis (FA), principal component analysis (PCA), multidimensional scal-
ing (MDS) [35] or hierarchical clustering. The described approaches aim
to identify groupings within samples. Alternatively, groupings within sub-
strates, can be identiﬁed by calculating the pairwise covariances or distances
between the substrates rather than between samples. Another common
method in addition to using summary statistics or model parameters, is to
make a binary growth versus no-growth distinction, for example, based on
an arbitrary threshold or by comparing curves to a reference curve [7, 31].
In this approach, the distances between the resulted binary vectors can be
deﬁned as Hamming distances. One recently published method describes
individual metabolic curves in terms of the number and nature of metabolic
cycles present in an experiment due to sequential use of diﬀerent metabolic
pathways, or the presence of subpopulations in the samples [39]. Simi-
lar to any other summary statistic, these measures can be utilized when
comparing samples.
Similar to gene expression microarray data, preprocessing of PM data is
required before performing any of the above described statistical analyses.
The most essential preprocessing steps, background correction and normal-
ization, make the samples comparable with each other, and thus the results
more reliable. All PM plates contain at least one control well (usually well
A01) and in the background correction, the signals produced by the control
well are subtracted from the other metabolic proﬁles. Normalization, on the
other hand, removes systematic errors from the experimental data. Such
errors may be caused by diﬀerences, for example, in array quality, sam-
ple preparation, equipment, laboratories, technicians, or number of cells
pipetted into the plates.
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Figure 2.3: A workﬂow for detecting similar metabolic activity patterns within
samples. First panel: raw or background corrected metabolic curves of n samples. Second
panel: summary statistics of n × 96 curves collected into a matrix. Third panel: pairwise
distances between samples, for example, based on Euclidean distance or covariance. Fourth
panel: clustering of samples by dimension reduction methods, such as FA, PCA and MDS, or
hierarchical clustering.
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Area under the curve (AUC) = the area under the metabolic activity curve
Lag phase = the phase prior to rapid growth. During the lag phase, bacteria adapt themselves
to the substrate conditions.
Slope = describes the steepness of the curve/maximal growth rate
Growth model = a mathematical model that can simulate a process studied over time
Spline ﬁt = a piecewise polynomial function where each sub-function is most commonly a cubic
function
Factor analysis (FA) = a statistical procedure that converts correlated variables into a smaller
set of linearly uncorrelated variables called factors. The observed variables are modelled as
linear combinations of the factors, plus error terms, i.e. X = CF+E, where X is a matrix
including the observed variables, C a matrix of loadings, F a matrix including the factors, and
E a matrix of error terms.
Principal component analysis (PCA) = a statistical procedure that converts correlated variables
into a smaller set of linearly uncorrelated variables called principal components. The principal
components are modelled as linear combinations of the observed variables, i.e. P = CX, where
P is a matrix including the principal components, C a matrix of loadings, and X a matrix
including the observed variables.
Multidimensional scaling (MDS) = a statistical procedure that projects observed distances
of study objects (e.g. samples, or substrates) into a reduced number of variables/dimensions
by minimizing the change in the between-object distances. In contrast to PCA and FA, any
similarity or dissimilarity matrix, in addition to correlation matrix, can be used.
Hierarchical clustering = a statistical procedure that converts the distances between the objects
studied into a dendrogram. For example, Euclidean or Hamming distances can be used as a
dissimilarity measure between objects.
Euclidean distance = in a two-dimensional space the distance between points p = (p1, p2) and
q = (q1, q2) is
√
(p1 − q1)2 + (p2 − q2)2. For n-dimensional space, this can be extended as√∑n
i=1(pi − qi)2
Hamming distance = for two vectors of equal length, the number of positions at which the
corresponding symbols are diﬀerent
2.1.1 Methods introduced in article I
In article I, we introduce a three-step pipeline for analyzing PM data includ-
ing 1) a binary grouping of the metabolic curves into active and inactive,
2) normalization, and 3) comparison of samples. All the methods are mo-
tivated by the hypothesis that the metabolically active and inactive wells
should be treated separately when analyzing PM data. Especially, the ex-
isting methods for normalizing PM data suﬀer from the combined analysis
of the inactive and active wells, and in the comparison of samples, the
inclusion of wells in which no metabolic activity occurs, is not necessary
either.
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Figure 2.4: Grouping of metabolic activity curves into active and inactive by
using the EM-algorithm. The 96 growth curves shown by pink and yellow colours represent
the metabolic activity curves produced by the 96 wells of a single plate. Black dotted line at
100 is a cut-oﬀ for the activity (curves not exceeding this level are never considered as active).
At each iteration, two steps are performed: 1) grouping and 2) model ﬁtting. Iteration 1: 1) an
initial grouping into active and inactive is performed based on the activity cut-oﬀ, i.e. curves
not exceeding the cut-oﬀ of 100 at any time point are assigned to the inactive group (yellow),
whereas the curves exceeding the cut-oﬀ at least at one time point are assigned to the active
group (pink), then 2) a mixture of linear and logistic model (linear to the inactive and logistic to
the active) is ﬁtted, and shown as black solid lines. Iteration 2 & 3: 1) each curve is reassigned
either to the active or inactive group based on whether it resembles more the linear or the logistic
curve ﬁtted at the preceding iteration, then 2) the mixture model is reﬁtted according to the
new grouping. Here, only three iterations are needed for the solution to converge.
The grouping into active and inactive is done by applying the Expectation-
Maximization (EM) algorithm [40, 41] iterating between two states: 1) ﬁt
a mixture of a linear and logistic model, and 2) assign each curve to the
most probable group. The linear model is reserved for the inactive, whereas
the s-shape of the logistic curve is assumed to describe well the curves pro-
duced by the metabolically active wells. The EM algorithm proceeds until
the likelihood of the mixture model convergences to its maximum, or the
maximum number of iterations is reached. All the curves on a plate are
evaluated at once, resulting in a grouping that is relative to the degree of
metabolic activity on a plate, i.e. if the metabolic activity on a plate is in
general low, curves with a relatively low metabolic activity are addressed
as active. The comparability between plates can be enhanced by deﬁning
a cut-oﬀ for the activity, i.e. the curves not exceeding the given value are
never labelled as active. The same cut-oﬀ is utilized to deﬁne the initial
grouping, which in part helps to restrict the number of iterations. Figure
2.4 illustrates the step-wise EM approach for grouping.
The existing solutions for normalization can result in biased curves,
as they often divide the raw signals by a measure called the average well
colour development (AWCD) which becomes under-estimated if many of
the curves are inactive. Additionally, the resulting normalized curves often
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lack the shape of growth curves, preventing the ﬁtting of growth models
to them. Our normalization method utilizes the above gained distinction
into active and inactive curves as well as considers the ﬁtted mixture model
as the average metabolic behaviour on a plate. However, as the average
metabolic proﬁles of replicated measurements are compared and adjusted
against each other, at least three replicates are required to accomplish the
normalization.
The third step, comparison of samples, utilizes the grouping into ac-
tive and inactive as well. Now, linear or logistic model is ﬁtted to a single
curve instead of a group of curves. In comparison to the existing meth-
ods [37], the aim of model ﬁtting is noise reduction rather than comparison
of the resulting parameter estimates. Hence, instead of using the model
parameters, we use the predicted values to detect diﬀerences in metabolic
activity between samples. The statistical testing is performed by applying
a Bayesian two-way analysis of variance (ANOVA) at several time points.
The approach enables testing the main eﬀects of two categorical indepen-
dent variables on the metabolic activity as well as their interaction eﬀect.
In the experimental data represented in the article, the metabolic activity
of several Yersinia enterocolitica strains is observed at diﬀerent tempera-
tures 1. In this example, we are able to assess the main eﬀects of strain
and temperature and their interaction. In the case of two strains tested at
two temperatures, interaction can, for example, imply to strains diﬀering
in their metabolic activity at the higher temperature, but showing no dif-
ferences at the lower temperature. Such a pattern is illustrated in Figure
2.5.
1Temperature can be easily adjusted by the OmniLogTM incubator-reader, and for
many bacteria their metabolic activity at diﬀerent temperatures is of interest.
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Figure 2.5: Detection of diﬀerences in the metabolic activity samples. Left: 12
normalized metabolic activity curves are categorized into four groups according to temperature
and strain, each setting including three replicates. Coloured dots represent model-based predicted
response values at eight time points, at each of which a Bayesian ANOVA is applied (values
at three time points are circulated). The experimental group represented by black colour is
considered as a control group, against which the others are compared to. Thus, temperature eﬀect
refers to the diﬀerence between the black and green curves, and strain eﬀect to the diﬀerence
between the black and red curves. If no interaction between temperature and strain exists,
equal eﬀect as is present between temperatures for strain 1 (black and green) would also be
present between temperatures for strain 2 (red and blue). Similarly, equal eﬀect as is present
between strains at low temperature (black and red) would also be present between strains at high
temperature (green and blue). Right: Estimated eﬀects with their 95 % credible intervals. An
eﬀect is considered statistically signiﬁcant if its credible interval does not contain zero. We see
that temperature eﬀect is signiﬁcantly positive throughout the experiment (green), whereas strain
eﬀect (red) is signiﬁcant only at the beginning and at the end, and changes its direction from
positive to negative in between. Since the interaction (blue) is signiﬁcant, the temperature eﬀect
present in strain 1 is not present in strain 2, and similarly the strain eﬀect at high temperature
is diﬀerent from the (mainly non-existing) eﬀect at low temperature.
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EM-algorithm = an iterative method for ﬁnding maximum likelihood estimates for two sets of
unknowns: model parameters and unobserved latent variables. One can choose arbitrary values
for one of the two sets of unknowns, use them to estimate the second set, and then use these
new values to ﬁnd a better estimate of the ﬁrst set. If one keeps alternating between the two
sets, the resulting values will both converge to ﬁxed points.
Mixture model = a probabilistic model for representing data that are generated from several
distributions
Linear model = a straight line ﬁtted to data points to assess the relationship between two
variables
Logistic model = an S-shaped (sigmoid) curve ﬁtted to data points to assess the relation-
ship between two variables. Traditionally used for describing such population growth that
the initial stage of growth is approximately exponential before slowing down and ﬁnally stopping.
Likelihood = probability of observed outcomes given a statistical model and its parameters
Active/inactive curve = a metabolic proﬁle produced by an active/inactive well
Average well colour development (AWCD) = the mean colour intensity over samples in a well
calculated at each measured time point
Noise = errors occurring during the measurements diminishing the precision of the true signals
Bayesian statistics = a theory in the ﬁeld of statistics which in addition to making statistical
inference only based on a likelihood model includes prior knowledge about the model parameters
(One-way) ANOVA = a generalization of the t-test to more than two groups for testing whether
the means of several groups are equal. In other words, ANOVA examines the inﬂuence of one
categorical independent variable on one continuous dependent variable.
Two-way ANOVA = a generalization of the one-way ANOVA to examine the inﬂuence of two
categorical independent variables on one continuous dependent variable
Main eﬀect = the inﬂuence of an independent variable(s) on a dependent variable
Interaction = the inﬂuence of an independent variable on a dependent variable depends on the
category of another independent variable
2.1.2 Methods introduced in article II
Article II introduces another pipeline called FLOG for studying Biolog
metabolic curves. The approach is designed for visual inspection rather
than for statistical testing of metabolic diﬀerences. However, the eﬀects de-
tected by FLOG can be tested, for example, by using the Bayesian ANOVA
approach introduced in article I.
The method is motivated by the multidimensional nature of the Biolog
data, and designed for comparing several samples. In comparison to the
traditional methods described above and, for example, in [38], this method
does not require replicates. The outline of the approach is similar to the
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framework demonstrated in Figure 2.3, with the exception that three sum-
mary statistics are used instead of a single value. The statistical basis of
the method is factor analysis rather than PCA or MDS.
The aim was to implement a straightforward pipeline for getting an
overview of vast amounts of Biolog data by reﬂecting the originally multi-
dimensional data into a two- or three-dimensional factor space, and clus-
tering the samples based on their factor loadings. Additionally, each single
curve or the mean metabolic curve of the samples within a cluster is plotted
for a visual inspection of either similarities or diﬀerences within or between
the clusters. Based on our experience, the tool nicely enables the detection
of outlying samples, replicates, or other groups with dissimilar metabolic
patterns. The advantage of using FLOG is that features speciﬁc to Bi-
olog data, such as background correction, normalization, and exclusion of
inactive wells, are taken into account in the pipeline. Also several PM
plates can be simultaneously analyzed. Furthermore, FLOG is compatible
with the pipeline introduced in article I, thus in addition to performing
factor analysis, the data can be grouped, normalized and compared with
the existing R functions.
FLOG = Factor analysis + BioLOG
Multidimensional Biolog data = Biolog data are multidimensional by nature as thousands of
phenotypes are tested simultaneously, and additionally at hundreds of time points
Factor space = a space deﬁned by uncorrelated factors that depicts the most of the variation in
the observed data points
Factor loading = the strength of the relationship between a data point and a factor
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Figure 2.6: Reﬂection of the originally multidimensional Biolog data into a
three-dimensional factor space. Factor analysis is applied on the summary statistics of
the metabolic activity curves represented in Article II. Data include 98 samples, of which 18 are
categorized as wild-type samples and 80 as single gene knock-out mutants. The resulting factor
solution is represented as three-dimensional plots, each of which show the same factor solution
with varying clustering. Top: factor loadings clustered by k-means with k = 3. Middle: factor
loadings clustered by k-means with k = 4. Bottom: factor loadings coloured according to the
wild-type/mutant status of the samples. The fading colours and the tails visualize the position
of the loadings on the third factor.
Chapter 3
Genome-wide association studies
(GWAS)
The genetic basis of each living cell is the DNA (deoxyribonucleic acid)
molecule, a sequence of nucleotides alternating between four bases: cytosine
(C), guanine (G), adenine (A), and thymine (T). The size of an organism’s
genome is generally considered as the total number of bases. For a human,
the genome size is about 3 billion (3 × 109) bases, and the order of the
nucleotides is highly constrained. In fact, the DNA of any two persons
is 99.5 % - 99.9 % identical, depending on the source [42, 43]. Yet, the
subtle variation that remains, makes each person unique with diﬀerent hair
colours, facial structures, and other traits. The small diﬀerences in our
genomes are also a key factor in tracking causes of some diseases, such
as hereditary breast, and colorectal cancer, or Parkinson’s and Crohn’s
disease [44, 46–49]. Genome-wide association studies (GWAS) provide a
tool for identifying such genetic variants involved in the development of
human diseases and individual traits.
The most common type of genetic variation among people is single
nucleotide polymorphism (SNP), found on average once in every 300 nu-
cleotides [50]. As the name suggests, SNP is a single nucleotide diﬀerence
at a certain base position of the DNA sequence. For example, at a SNP,
the nucleotide C may be replaced with the nucleotide T. Most SNPs so
far discovered include only two variants (bi-allelic SNP), but there are also
SNPs in which three diﬀerent base variations coexist [51]. In bi-allelic SNPs
one variant is present less frequently than the other, and the frequency of
the less frequent allele is referred as the minor allele frequency (MAF). The
human genome contains roughly 10 million SNPs for which the MAF is 5
% or more, i.e. both variants are found in at least 5 % of individuals in
the human population.
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SNPs are not the only type of genetic variation, as human genome also
contains larger regions that are deleted, duplicated, repeated, or inverted.
Such genetic markers are called copy-number variations (CNVs). How-
ever, when applying GWAS, SNPs are preferred over other genetic mark-
ers, because of their high abundance, relatively low mutation rate, and easy
adaptability to automatic genotyping.
At its simplest, GWAS tests for non-random distribution of nucleotides
between two groups of people: cases and controls. The testing is most often
done one SNP at a time, and a SNP is considered as causal for a particular
disease if it occurs signiﬁcantly more frequently in people with the disease
(case) than in people without the disease (control), and it introduces, for
example, a nonsynonymous change to a coding sequence or alters gene
regulation. Ideally, the controls are matched as closely as possible with the
cases in other respects than in terms of the disease status. Table 3.1 shows
an example distribution for two alleles at a single SNP. Whether either of
the alleles occurs more frequently among the cases than controls, can be
tested, for instance, by χ2-test.
Table 3.1: Distribution of alleles at a bi-allelic SNP.
Disease status
Allele case control total
C 23 11 34
T 73 15 88
total 96 26 122
As the human genome contains millions of SNPs, it would be diﬃcult,
time-consuming, expensive and ineﬀective (in terms of statistical power) to
look for changes in each of these. Therefore, genotyping eﬀort is greatly
reduced, as well as the statistical power increased, by utilizing the assump-
tion that SNPs close to each other in a chromosome are inherited together,
forming correlated clusters of SNPs known as haplotype blocks in which
SNPs are predictive of each other [52]. Thus, instead of measuring mil-
lions of SNPs, it is suﬃcient to collect a smaller fraction of tag SNPs from
the haplotype blocks. Also it is easier to detect loci associated with a
phenotype, especially if there are many SNPs strongly correlated with the
causal SNP. The phenomenon of correlated loci is also known as linkage
disequilibrium (LD).
Once a disease-causing SNP is detected, strategies for diagnosis or pre-
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vention of the disease can be suggested. For example, the discovery of a
SNP associated with lactase persistence provided a new approach for di-
agnosing patients with lactose intolerance: the earlier used, uncomfortable
examination provoking symptoms of lactose intolerance could be replaced
with a genetic test which can easily be taken from a blood sample [4, 17].
Another example is the prevention of hereditary breast cancer caused by
pathogenic variants in BRCA1 or BRCA2 genes [44]. The options for pre-
vention are regular breast screenings, a surgery to remove breasts (and
possibly ovaries), or medicines to lower the risk of developing cancer.
In addition to causing diseases, or increasing the risk of them, diﬀerences
in genetic composition can aﬀect individuals’ response to pathogens, chem-
icals, drugs, vaccines, and other agents, thus allowing the design of tailored
treatment for patients according to individual genetic features [45].
Nucleotide = a biological compound of a nitrogenous base (A, C, G, T), sugar, and a phosphate
group
Nonsynonymous change = a nucleotide mutation in the DNA sequence that alters the resulting
amino acid sequence of a protein in contrast to not altering which would then be considered as
a synonymous change
χ2-test = a statistical hypothesis test to determine whether there is a signiﬁcant diﬀerence
between the expected and the observed frequencies in one or more categories of a contingency
table
Statistical power = the ability of a test to detect an eﬀect, if the eﬀect actually exists, i.e. low
power means that real eﬀects remain undetected
Concerns related to GWAS
There are some complications related to performing genome-wide associ-
ation studies. Starting from scratch, both genome sequencing and SNP
calling are delicate multi-step processes and as such prone to errors. Thus,
the accuracy of the techniques used in sequencing and deﬁning the single nu-
cleotide diﬀerences between sequences, directly reﬂects to the downstream
genomic analyses, such as GWAS [53,54].
For many common disorders, like heart diseases, diabetes or cancer,
there exists no single SNP suﬃcient to cause the disease, i.e. these dis-
eases are due to the combined eﬀect of several genetic variants, making the
genome-wide analysis more complicated [55]. Additionally, other factors,
such as environment, have a signiﬁcant role in the development of many
diseases, such as lung cancer [56].
Some diseases are rare, and thus diﬃcult to study in terms of collecting
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large enough sample sizes. Some genetic variants are rare as well. When
only a few people in a study carry a variant, large sample sizes are required
to detect patterns in the genetic composition. Some rare variants are quite
young, and partly due to the increased opportunities for mutations to occur
during the rapid growth of human population since the beginning of the
20th century [57, 58]. In some diseases, both rare and common genetic
variants have a combined eﬀect on the risk of the disease, thus complicating
the analyses [59].
The advantages of haplotype blocks and LD were discussed above, how-
ever LD also introduces some problems to the genome-wide analysis of ge-
netic variants, as it might be diﬃcult to locate the causal SNP among the
correlated SNPs, especially if there are many SNPs in strong LD with the
causal SNP [60].
Yet another problem is introduced by sub-populations, as a SNP al-
lele common in one geographical or ethnic group may be much rarer in
another. Therefore, causal SNPs found by GWAS for any phenotype that
varies across sub-populations are likely predictive of the individual’s sub-
population of origin rather than the studied phenotype. Clearly such pop-
ulation structures need to be accounted for in the analysis to avoid false
positive discoveries. However, the underlying population structures are not
always known in advance, and thus need to be estimated.
Finally, the testing of thousands of SNPs at a time introduces a problem
of multiple hypothesis testing, reducing the power of detecting the truly
causal SNPs.
Genome sequencing = reading the bases of a DNA sequence
SNP calling = ﬁnding sites that vary between the compared genome sequences
Rare (genetic variant) = a genetic variant, for example, a SNP that occurs at a low frequency
in a population
Multiple hypothesis testing = considering a set of statistical hypothesis simultaneously making
it more likely to ﬁnd statistical signiﬁcance by random chance alone
3.1 GWAS in bacteria
In terms of bacteria, researchers are interested in ﬁnding genetic variants
associated with a wide variety of phenotypes, such as host, geographical
area, pathogenicity or lineage. Currently, especially intriguing is solving
the genetic factors behind antibiotic resistance of bacteria, as many human
pathogens have developed the ability to adapt and overcome antibiotics,
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complicating the treatment of diseases caused by bacteria [61]. Many bac-
teria are resistant to multiple types of antibiotics, even to all available an-
tibiotics, as well as can develop resistance during an ongoing treatment. Ex-
amples of such multi-drug resistant species are methicillin-resistant Staphy-
lococcus aureus (MRSA) which is a major source of hospital-acquired in-
fections, Pseudomonas aeruginosa and Mycobacterium tuberculosis.
However, association studies are not as widely applied for bacteria as
they are for human [18–20]. This is due to various reasons, for instance,
it has become suﬃciently aﬀordable to sequence hundreds or thousands
of isolates from a bacterial population only very recently, and before this
population genomic era association studies in bacteria were restricted to
candidate genes. Other complications arising in bacterial GWAS are the
clonal population structure and restricted recombination in bacterial pop-
ulations [18, 19, 62]. The clonal population structure is due to an asexual
reproduction process in which an oﬀspring inherits the genes of its parent,
resulting in oﬀsprings identical, or nearly so, to their parents. Human ga-
mete cells, instead, are produced by meiosis in which recombination, i.e.
exchange of genetic material between chromosomes occurs naturally, re-
sulting in oﬀsprings whose DNA content diﬀers from that of the parent.
Since the eﬀectiveness of GWAS in detecting genetic relationships depends
crucially on the degree of variation introduced in the compared sequences
by recombination, association studies are of limited value for completely
clonal or infrequently recombining organisms. In other words, in bacteria
recombinations occur too rarely to break the genetic material into blocks
where the causal parts could be distinguished from the non-causal ones by
computational means. Additionally, strong population structure in bacte-
ria can produce false positive discoveries and loss of statistical power in
detecting causal variants.
Even though bacterial homologous recombination is restricted in gen-
eral, it does occur via several molecular mechanisms. This process is often
called lateral or horizontal gene transfer (LGT/HGT), but it may also more
generally introduce non-homologous DNA and alter the gene content of a
bacterial chromosome. The main modes of HGT are typically categorized
into three diﬀerent processes in which a living cell can uptake DNA from
its surroundings (transformation), from other bacteria (conjugation), or
with the assistance of bacteriophages (transduction) [63,64]. Although the
study of recombination is restricted due to the clonal structure of bac-
terial populations [65, 66], the recombination rates have been detected to
vary considerably across species [64, 67]. Streptococcus pneumoniae, Pseu-
domonas aeruginosa and Helicobacter pylori are examples of species with
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a high recombination rate, Burkholderia pseudomallei and Campylobacter
jejuni have intermediate recombination rate, and E. coli is typically asso-
ciated with a low homologous recombination rate. It should be remarked
that despite of generally low levels of homologous recombination, an E. coli
population still may be experiencing gene gain and loss through HGT at a
very high rate as exempliﬁed by the recent study of the global pandemic
clone ST131 [21].
Host = source of bacteria, e.g. human, cattle, poultry
Human pathogen = a virus, bacterium, prion, or fungus that causes disease in humans
Asexual reproduction = the primary form of reproduction for single-celled organisms which
does not require fusion of gametes
Gamete = a mature sexual reproductive cell, such as sperm or egg, that unites with another cell
to form a new organism
Population structure in bacteria = diverse genetic composition within or between bacterial
species due to recombination or mutations
Lateral/horizontal gene transfer (LGT/HGT) = a mode of recombination in bacteria to transmit
DNA between diﬀerent genomes, for example, in order to spread a beneﬁcial gene that produces
more durable organisms, or to ensure the survival of a species
Homologous recombination = a major DNA repair process in bacteria in which nucleotide
sequences are exchanged between two similar or identical molecules of DNA
Non-homologous recombination = a type of recombination in which a nucleotide sequence is
translocated into a new position in a genome
3.1.1 Sequence element enrichment analysis (SEER)
In article III, we introduce a new approach, sequence element enrichment
analysis (SEER), for applying bacterial genome-wide association analysis.
Instead of SNPs, we test whether sequence elements, more generally known
as k-mers, are over- or under-represented within a phenotype. K-mers,
i.e. DNA words of length k, have been used for numerous purposes in
bioinformatics, for instance for assembling sequencing reads to contigs [68],
and to building alignment-free phylogenies [69]. The beneﬁt of k-mers over
SNPs in GWAS is that they capture several diﬀerent types of variation
present in genomes as well as expand the search of genetic variants to
accessory genomic regions instead of only focusing on the core genome.
SEER is compiled into a pipeline which provides several alternatives
for the input data, counting k-mers, performing analysis, and representing
the results. The possibly underlying population structures are revealed
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by estimating the genetic distances between the isolates by constructing
a distance matrix based on a random subset of k-mer occurrences. An
example of the binary k-mer occurrence vectors where the presence of a
single k-mer is recorded as a binary variable, i.e. present or absent, is shown
in Table 3.2. The table also illustrates, how the pairwise distances are
calculated. Multidimensional scaling (MDS) is then applied on the distance
matrix constructed of the pairwise distances, and the eigenvectors of the
MDS projection used as covariates when testing for associations. If three
eigenvectors explain the variation in the data, the population structure can
be represented as a three-dimensional plot as illustrated in Figure 3.1.
Table 3.2: K-mer occurrence vectors of length m for n isolates
represented in a matrix.
k-mer
Isolate 1 2 3 4 5 6 7 8 . . .m
1 1 0 0 1 0 0 0 1 . . . 1 Hamming distance e.g. between isolates 1 and 2:
2 1 1 0 0 0 1 0 1 . . . 1 0 + 1 + 0 + 1 + 0 + 1 + 0 + 0 + . . . 0
3 0 1 0 0 1 0 0 1 . . . 0
.
.
.
n 0 0 0 0 0 0 1 1 . . . 1
Each row in the matrix represents an occurrence vector for a single isolate. A random subset of
0.1 - 1 % of all the k-mers is used, and for each presence in a particular sample coded by 1, and
absence by 0. Pairwise Hamming distances are calculated and collected into a matrix (matrix
representation is not shown here).
The phenotype, such as response to antibiotic treatment, is also con-
sidered as binary. In a similar fashion to SNPs (Table 3.1), the data for
k-mers can be represented as a 2 × 2 contingency table as shown in Table
3.3.
The association of the antibiotic resistance to the presence or absence
of a k-mer can be tested by applying a logistic regression model:
log
(
y
I− y
)
= β0 + β1x+ β2Z, (3.1)
where y is a binary outcome vector coding for the antibiotic response (1
if resistant, 0 if sensitive), x a binary vector coding for the k-mer presence
(1 if present, 0 if absent), Z a matrix containing the eigenvectors of the
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Table 3.3: Distribution of k-mers across resistant and sensitive
samples.
Antibiotic response
K-mer presence resistant sensitive total
absent 23 11 34
present 73 15 88
total 96 26 122
MDS projection and additional user-given covariates, and β’s include the
regression coeﬃcients (β0 and β1 are scalars and β2 is a vector). The eﬀect
of the k-mer presence on the antibiotic response is evaluated by testing
whether β1 = 0. If β1 < 0, the k-mer is considered under-represented
within the resistant samples, and similarly if β1 > 0, over-represented.
In logistic regression, rare outcome events, i.e. if in either of the pheno-
type groups, the tested k-mer is found in few or none of the samples, or it is
found in nearly all of the samples, cause problems in ﬁtting the model which
can be detected as large standard errors. A similar event occurs when the
continuous population structure covariates predict the outcome phenotype
too perfectly, or in other words, the population structure is strongly cor-
related with the phenotype (see Figure 3.1). This phenomenon is known
as (perfect) separation, and is overcome in SEER by invoking Firth regres-
sion [70] in which the likelihood function is penalized by a factor known as
Jeﬀreys prior, the eﬀect of which diminishes as sample size increases:
L(β)Firth = L(β)|I(β)| 12 , (3.2)
where L(β) is the likelihood function in terms regression parameters β
and |I(β)| 12 the penalizing factor, where |I(β)| is the determinant of the
information matrix evaluated at β.
In general, logistic regression can be utilized when the outcome variable,
i.e. phenotype, is dichotomous, and the predictor variable, i.e. genotype,
is categorical, or continuous. So far, only dichotomous phenotypes have
been discussed, however SEER also incorporates the analysis of continuous
phenotypes by applying linear regression instead of the logistic regression
[3.1].
A typical dataset analyzed by SEER contains hundreds of samples, each
of which is a DNA sequence millions of bases long, thus yielding millions
of k-mers to be analyzed. Typical to GWAS, all the variant sites, whether
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Figure 3.1: K-mer distances projected into three MDS dimensions estimating
underlying population structures. Axes are scaled between -1 and 1. Left: Population
structure in the Streptococcus pneumoniae data analyzed in article III. Colouring is based on
hierarchical clustering of the Hamming distance matrix, and thus compares the continuous MDS
solution against a categorical clustering solution. Right: Population structure correlated with a
phenotype. Colouring is based on two phenotype groups. Such a strong separation in terms of
the phenotype may cause problems in ﬁtting the logistic model in SEER.
SNPs or k-mers, are tested one at a time, creating the problem of multiple
hypothesis testing as well as an enormous computational burden. SEER
tackles these problems by setting a strict cut-oﬀ level for p-values, using an
eﬀective C++ coding environment, reducing the number of k-mers tested
with the logistic model [3.1] by pre-ﬁltering the k-mers with a χ2-test,
and using a step-wise approach when solving the model parameters, i.e. a
faster, but more error prone algorithm is ﬁrst applied, and only if needed
a more successful, but more time consuming option. As discussed above,
problems in ﬁtting the logistic model caused by separation are overcome by
adding an adjustment to the likelihood function when solving the regression
coeﬃcients (see Equation 3.2).
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Accessory genome = genetic material not present in all the genomes compared
Core genome = genetic material present in all the genomes compared
K-mer occurrence = whether a k-mer is detected or not in a particular isolate
Binary variable = a variable with two categories speciﬁed as 0 and 1
Multidimensional scaling (MDS) = a statistical dimension reduction procedure that projects
observed distances of study objects (e.g. samples) into a reduced number of variables/dimensions
by minimizing the change in the between-object distances. In contrast to PCA and FA, any
similarity or dissimilarity matrix, in addition to correlation matrix, can be used.
Eigenvector = a vector capturing the between-object distances
Covariate = a variable that is maybe not of direct interest but possibly predictive of the outcome
under study
Regression coeﬃcient = the strength and direction of the relationship between the dependent
variable and explanatory variable(s) in a logistic or linear regression model
Jeﬀreys prior = a non-informative prior for the parameters of a probability model utilized in
Bayesian theory
Determinant = a useful value that can be computed from the elements of a square matrix
Information matrix = the expected values of the second partial derivatives of the log-likelihood
function in terms of the unknown parameters
Dichotomous variable = a variable with only two categories or levels
3.1.2 Applications of SEER to real data
We have applied SEER to over a dozen of bacterial studies with a variety of
phenotypes of interest, such as host, age of the host, geographical location,
antibiotic resistance, and invasiveness, and have been able to discriminate
genetic variants speciﬁc to these features. Table 3.4 summarizes some of
these applications by specifying the bacterial species studied accompanied
with the length of its genome, the tested phenotype, the number of samples
per group and in total, as well as the number of distinct and signiﬁcant k-
mers of length between 9 and 100.
As indicated in Table 3.4, the most studied genus is Streptococcus for
which we have investigated the species: Streptococcus suis, Streptococcus
pneumoniae and Streptococcus pyogenes. The length of a bacterial genome
is, in general, some millions of base pairs varying here roughly from two to
six million base pairs. In comparison to the human genome, the bacterial
genome is about 1000 times smaller. Among the species studied, Strepto-
cocci and Campylobacter jejuni have the shortest genomes of about two
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Table 3.4: Several of the SEER applications considered by the
author.
Species Ref. Genome Phenotype Sample size K-mers
sizea Group Total Distinct Sig.
Streptococcus suis Article IV 2.1 Host 38/153 191 3b .
Streptococcus pneumoniae Article III 2.3 Antibiotic resistance 179/2890 3069 12b IIIII
585/2484 3069 20b III
1171/1898 3069 30b IIII
768/2301 3069 30b IIIII
Streptococcus pyogenes Article III 1.9 Invasiveness 185/489 674 25 I
Pseudomonas aeruginosa 6.3 Antibiotic resistance 40/177 217 47 .
29/188 217 47 .
42/175 217 47 .
42/175 217 47 .
88/129 217 47 .
87/130 217 47 .
11/202 213 47 .
89/127 216 47 .
79/137 216 47 .
100/116 216 47 .
72/144 216 47 .
80/137 217 47 .
12/201 213 47 III
40/177 217 47 II
38/179 217 47 II
21/190 211 47 II
Burkholderia pseudomallei [22] 3.2 Geographical location 11/290 301 0.55b II
9/292 301 2b III
9/292 301 2b IIII
63/238 301 2b IIII
103/198 301 8b II
Escherichia coli [21] 5.0 Multi-drug resistance 227/722 949 100 IIIII
Campylobacter jejuni [23] 1.7 Geographical location 141/175 316 8 III
Salmonella 4.7 Lineage 245/252 497 2b IIII
H3N2c 0.014 Vaccination 112/183 318 0.019 .
The table summarizes some of the applied SEER applications by specifying the species studied,
a reference to the SEER study, an approximate length of the genome studied, the phenotype
tested, the number of samples per group and in total, as well as the number of distinct and
signiﬁcant k-mers found. The categorization for the signiﬁcant k-mers is the following:
Number of signiﬁcant k-mers found
0 .
1− 102 I
102 − 103 II
103 − 104 III
104 − 105 IIII
> 105 IIIII
a Genome size in millions base pairs; Source: http://www.kegg.jp/kegg/genome.html
b Preﬁltered
c Virus
million base pairs, while Pseudomonas aeruginosa, E. coli and Salmonella
have the longest genomes of about ﬁve to six million base pairs.
All the phenotypes tested are dichotomous, meaning that the logistic
regression model [3.1] was applied in SEER when searching for k-mers en-
riched in either of the phenotype groups. The sample sizes vary from 191
to 3069, being on average some hundreds. The most eﬀective study design
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would contain an adequate and equal number of samples in both of the
phenotype groups. However, as can be observed, the settings rarely are
balanced, mainly due to the phenotype of interest being rare. For example,
not many samples were available from the same geographical location in
the Burkholderia pseudomallei study. A mild unbalance may not aﬀect the
results, but if either of the groups has too few observations, it decreases
the power of detecting enrichment as well as increases the number of false
positive signals.
The number of distinct k-mers found is dependent on, e.g., the length of
the genome, number of the samples, length of the actual sequences provided,
spectrum of k-mer lengths (in these data sets k-mers between 9 and 100
were extracted) and the overall similarity between the compared strains.
For some studies, k-mers were ﬁltered during scanning, hence decreasing
the number of k-mers found. In Table 3.4, the number of distinct k-mers
varies between 550, 000 and 100 million (19, 000 for H3N2 virus).
The number of signiﬁcant k-mers represented in Table 3.4 is the number
of k-mers before applying any additional ﬁltering which may be needed if
the number of signiﬁcant k-mers is vast, like for Streptococcus pneumoniae
and E. coli. Filtering reduces the amount of work when mapping the k-mers
back to a reference, and tracking the functions as well as the locations of
the k-mers. For most of the bacteria studied, SEER identiﬁed k-mers en-
riched within the phenotypes tested, i.e. genetic variants associated with
antibiotic resistance, pathogenicity, geographical areas, multi-drug resis-
tance and diﬀerent lineages seem to exist. For Streptococcus pneumoniae,
the antibiotic resistance determinants identiﬁed by SEER are previously
characterized [18], thus conﬁrming the performance of SEER in detecting
sequence elements associated with phenotypes.
For some bacteria, the k-mer contents do not vary between the phe-
notype groups, i.e. no enrichment or in other words genotype-phenotype
associations are detected. For example, in the Streptococcus suis study, rep-
resented in article IV, the genetic composition of isolates extracted from
human samples were compared against isolates from pigs. Streptococcus
suis is known as a swine pathogen, and of interest was to address the adap-
tation of the bacteria to the human population in Vietnam. The complete
data include isolates also from United Kingdom and China, but in this
part of the study, only the 191 isolates collected from Vietnam (38 from
pigs and 153 from humans) were used. An initial phylogenetic analysis
performed based on the complete data set and a discriminant analysis of
principal components based on the 191 Vietnamese isolates represented in
Figures 3.2 and 3.3, respectively, show no structuring of the isolates by
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host, indicating no consistent adaptation to the human population. To
verify this hypothesis genome-wide association analyses were applied on
the 191 Vietnamese isolates, both based on SNPs and k-mers, and, indeed,
no signiﬁcant associations were detected, i.e. no genetic variants, neither
SNPs nor sequence elements, appeared signiﬁcantly more often in isolates
from human than pig infections. It should be noted, however, that the
study had relatively low power due to a small number of genomes so it
cannot be excluded that host adaptive elements could be detected in larger
follow-up studies in the future.
Pathogenic abilities of the studied species
Most of the studied bacteria unlikely cause severe infections to healthy people, however people
with other illnesses or conditions, such as patients receiving chemotherapy for cancer, undergoing
a surgery, having cystic ﬁbrosis, HIV or AIDS, mechanical ventilator or catheter, or burn wounds,
are at a higher risk due to weakened immune response. Also, young children and elderly people
are at increased risk of bacterial infections.
Streptococci , in general, harbour the respiratory tract and skin of healthy hosts without signs
of disease, but when introduced to vulnerable tissues can cause severe infections. Streptococcus
suis is known as a swine pathogen, causing respiratory tract infections in pigs as well as inva-
sive diseases, such as arthritis, septicaemia and meningitis [71], but it can also infect humans.
Streptococcus pneumoniae or the pneumococcus, is instead a human pathogen causing both mild
(bronchitis, ear infection, sinusitis) and severe (blood poisoning, pneumonia, meningitis) infec-
tions. Streptococcus pyogenes has an ability to cause suppurative infections, mainly on skin, but
it also causes infections in throat, such as angina.
Pseudomonas aeruginosa is found in moist areas, such as soil and water, and can be the cause
of skin, ear, or eye infection originated, for instance, from an inadequately chlorinated swimming
pool. The more severe infections induced by P. aeruginosa are bacteremia (infection in blood)
and pneumonia (infection in lungs). P. aeruginosa is also a fairly common pathogen involved in
infections acquired in hospital settings.
Burkholderia pseudomallei , also found in soil and water, causes Melioidosis with pain in chest,
bones, or joints, cough, skin infections, lung nodules and pneumonia [22]. Melioidosis is endemic,
particularly to Thailand and northern Australia.
Escherichia coli naturally colonizes the lower intestine of humans and animals, and is probably
the most studied, and hence the best-known bacterial species. Most E. coli strains are harmless,
but some are pathogenic causing serious food poisoning due to contamination of food or water by
fecal matter as well as urinary tract infections, bloodstream infections, and meningitis. In devel-
oping countries, E. coli is a common cause of infant diarrhoea. Recently, sequence type ST131
has emerged as a major cause of serious multidrug-resistant extraintestinal E. coli infections [21].
Campylobacter jejuni and Salmonella are, in additon to E. coli, common causes of food-borne
intestinal infections [23].
H3N2 is a seasonal inﬂuenza virus.
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Figure 3.2: Phylogenetic tree of a virulent zoonotic clade of Streptococcus suis.
The tree shows 256 human and pig isolates collected from Vietnam, United Kingdom and China,
and is estimated from an expanded core genome. Terminal branches are coloured according
to the country and host of origin, and indicate some genetic structuring by country, but little
clustering by host. Especially scattered are the isolates extracted from pigs from Vietnam. The
clade denoted with an asterisk corresponds to the isolates shown in the right hand peak of Fig
3.3. Figure from article IV.
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Figure 3.3: Discriminant analysis of principal components, applied to 191 isolates
collected from human and pig hosts in Vietnam. The analysis is applied to SNPs in the
core genome, and to presence/absence data for genes in the accessory genome. The ﬁrst linear
discriminant function is shown, and the lack of separation between the distributions suggests
a lack of consistent genetic diﬀerences between isolates from the two host types. Figure from
article IV.
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Chapter 4
Discussion
In this thesis, the aim was to develop statistical analysis tools for two types
of data produced by modern high-throughput technologies. On one hand
Biolog phenotype microarray technology along with the most commonly
used, as well as novel, analysis methods were introduced; on the other
hand a new genome-wide association analysis approach, SEER, was pro-
posed to bacterial sequence data. Both settings and technologies address
their own requirements which need to be taken into account to be able to
produce adequate results. Additionally, easy to use pipelines and software
are fundamental in handling and processing the vast amounts of data.
As both methodologies produce a lot of information, dimension reduc-
tion methods are applicable and useful. These methods have originally
been developed in social sciences and psychometry [73, 74], but have more
recently started to appear in molecular biology, for instance, for grouping
genes in DNA microarray analysis [75, 76]. In the context of genome-wide
association analysis, we utilize dimension reduction for estimating the pop-
ulation structure, whereas in the context of Biolog phenotype microarrays,
these methods help to visualize the data and reduce the need for multiple
hypothesis testing, the problem of which is also present in genome-wide
association studies. SEER tries to diminish the eﬀect of testing multiple
hypothesis by limiting the number of tests by pre-ﬁltering as well as by
applying a strict cut-oﬀ for p-value.
Similar to any statistical testing, the data types covered in this thesis
require consideration of variables not included or controlled in the study. In
general, such characteristics are called confounding variables, and they are
known to aﬀect the results by clouding the real eﬀects [72]. In the context of
phenotype microarrays, laboratory conditions, the technician used, or the
number of cells pipetted are examples of such confounding factors, whereas
in the genome-wide association studies, the most crucial confounding factor
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is the population structure.
Well designed experiments control for confounding variables in advance,
for instance, by using the same equipment and laboratory personnel, match-
ing pairs of subjects based on the potential confounding factors and ran-
domly assigning the subjects to treatment groups. However, such control
is not always possible, for example, laboratory conditions are not identi-
cal if metadata are collected from several sources, or subjects can not be
randomly assigned to have a disease status, for instance, when studying
whether the genomes of bacteria isolated from cancer patients diﬀer from
non-cancer patients. If the eﬀects of confounding factors are not dimin-
ished when designing the experiment, they can still be taken into account
in the statistical analyses by measuring the variables and including them
as covariates in a statistical model. However, these variables are not al-
ways, or cannot be, measured. Therefore they often need to be estimated,
as is done in terms of the population structure in genome-wide associa-
tion analyses. In SEER, the population structure is estimated as well, and
included as a covariate in the regression model. In the context of Biolog
phenotype microarray experiments, confounding factors rarely are recorded
either. Therefore, our pipeline looks for hints of confounding eﬀects by com-
paring replicates. Then the eﬀects are diminished by applying a procedure
called normalization.
The future prospects in terms of the Biolog and genomic data include
combining the analysis of the two types of data. One approach to link
metabolic data with genome sequence data was suggested by Galardini et
al. [78]. It separately analyzes both the genetic and metabolic data, and
represents the results on the top of KEGG pathways. Another valid ap-
proach would be to ﬁrst look for genetic variants associated with a certain
disease or state by genome-wide association studies, then imply the revealed
mutation(s) into a cell, and address their metabolic consequences with Bi-
olog phenotype microarrays. However, the most intriguing approach would
consider Biolog data as the phenotype data in the genome-wide association
study. This would allow to detect correlations between the metabolic ac-
tivity and the genetic composition of an organism in a wider scale. At the
moment, such approaches are limited by the small amount of Biolog data
available as well as the multidimensional nature of the Biolog phenotype
data. Ideally, the association of multiple phenotypes with genetic factors
should be addressed at once, and not one phenotype at a time. Some
high-dimensional phenotypes have already been utilized in genome-wide
association studies [77], thus as soon as the sample sizes increase GWAS
should be applicable to Biolog phenotype microarray data as well.
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